Both in Pharmaceuticals
ARS Pharmaceuticals vs Arcturus Therapeutics Holdings
Over the past year SPRY returned −62.3% and ARCT returned +10.6%; their daily moves had a correlation of 0.24.
SPRY −62.3% ARCT +10.6%Growth of $1, one year, split-adjusted
| Metric | SPRY | ARCT |
|---|---|---|
| Price | $3.38 | $11.03 |
| Market cap | $336.1M | $313.5M |
| Today | −7.65% | −9.22% |
| 1 month | −18.0% | −16.5% |
| 6 months | −60.5% | +27.8% |
| Year to date | −71.0% | +79.9% |
| 1 year | −62.4% | +16.8% |
| Revenue growth (YoY) | +114.2% | −89.5% |
| Gross margin | 61.8% | 100.0% |
| Net margin | −185.2% | −803.8% |
| P/E (TTM) | — | — |
| Price / sales | 2.9× | 10.7× |
| Net cash | -$27.8M | $191.5M |
| Dividend yield | — | — |
| Volatility (60d) | 71.5% | 114.9% |
| Short % of float | 40.5% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).